LncRNA MEG3在甲状腺乳头状癌中的表达及对增殖、侵袭与转移能力的影响

摘要
图/表
参考文献(20)
相关文章 (0)

全文: PDF (1126 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨lncRNA MEG3在甲状腺乳头状癌中的表达意义以及对甲状腺乳头状癌细胞增殖、侵袭转移能力能力的影响。方法收集2012年5月~2015年12月于遵义医学院第五附属珠海医院手术切除的甲状腺乳头状癌标本以及对应的癌旁组织，采用real-time PCR技术分别检测68例甲状腺乳头癌组织中MEG3表达情况，并分析其表达情况与临床病理参数的关系；通过细胞转染技术构建MEG3高表达甲状腺癌TPC-1细胞系，利用CCK-8方法检测MEG3对甲状腺乳头状癌细胞增殖能力的影响；采用Transwell方法检测MEG3对甲状腺乳头状癌细胞侵袭迁移与转移能力的影响；利用Western blot方法检测过表达MEG3基因后对甲状腺乳头状癌细胞Snail2蛋白表达的影响。结果 lncRNA MEG3在甲状腺乳头状癌组织中的表达水平显著低于癌旁组织，差异有统计学意义（P < 0.05）；MEG3在甲状癌组织中的表达与肿瘤大小、TNM分期有关（P < 0.05），与其他病理参数无关（P ＞ 0.05）；TPC-1细胞系中过表达MEG3可使甲状腺乳头状癌细胞的增殖能力降低，并且能够抑制甲状腺乳头状癌细胞的侵袭与转移能力（P < 0.05）。real-time PCR和Western blot检测发现，过表达MEG3能够显著抑制Snail2基因与蛋白的表达（P < 0.05）。结论 lncRNA MEG3在甲状腺乳头状癌中表达显著降低且与甲状腺的发生发展相关。MEG3能够显著抑制甲状腺乳头状癌细胞的增殖能力，且能够通过抑制Snail2蛋白的表达抑制状腺癌细胞的侵袭与转移能力。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	崔大炜1 姜峰2 陈大欣2

关键词 ： MEG3, 甲状腺乳头状癌, 长链非编码RNA

Abstract：Objective To investigate the expression of lncRNA MEG3 in papillary thyroid carcinoma and explore the effect of MEG3 on proliferation, migration and invasion in PTC-1 cells. Methods 68 cases of papillary thyroid carcinoma specimens and paired normal tissue were collected after surgery from May 2012 to December 2015 in the Fifth Affiliated Hospital of Zunyi Medical College. The expression of MEG3 was analyzed by quantitative real-time PCR. The effect of MEG3 on proliferation in TPC-1 cells was detected by CCK-8 method. The effect of MEG3 on migration and invasion abilities of TPC-1 cells were analyzed by Transwell assays. The expression of Snail2 was detected by Western blot. Results The expression of MEG3 was lower in papillary thyroid carcinoma tissues than adjacent normal tissues (P < 0.05). The expression of MEG3 was related with TNM stage and tumor size (P < 0.05). Over expressed MEG3 significantly inhibited the proliferation of TPC-1 cells (P < 0.05). And MEG3 could decrease the abilities of migration and invasion by down regulating the expression of Snail2 (P < 0.05). Conclusion The expression of lncRNA MEG3 is lower in the papillary thyroid carcinoma and can inhibit the proliferation, migration and invasion of TPC-1 cells can be inhibited by the expression of Snail2.

Key words： MEG3 Papillary thyroid carcinoma lncRNA

引用本文:

崔大炜1 姜峰2 陈大欣2. LncRNA MEG3在甲状腺乳头状癌中的表达及对增殖、侵袭与转移能力的影响[J]. 中国医药导报, 2017, 14(32): 15-18,42.
CUI Dawei1 JIANG Feng2 CHEN Daxin2. The expression of lncRNA MEG3 and the influence of proliferation，migration and invasion in papillary thyroid carcinoma. 中国医药导报, 2017, 14(32): 15-18,42.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2017/V14/I32/15

[1] Davies L，Welch HG. Thyroid cancer survival in the United States：observational data from 1973 to 2005 [J]. Arch Otolaryngol Head Neck Surg，2010，136（5）：440-444.
[2] Roman BR，Morris LG，Davies L. The thyroid cancer epidemic，2017 perspective [J]. Curr Opin Endocrinol Diabetes Obes，2017，24（5）：332-336.
[3] Rao A，Rajkumar T，Mani S. Perspectives of long non-coding RNAs in cancer [J]. Mol Biol Rep，2017，44（2）：203-218.
[4] Zhang R，Hardin H，Chen J，et al. Non-Coding RNAs in Thyroid Cancer [J]. Endocr Pathol，2016，27（1）：12-20.
[5] Zhang D，Liu X，Wei B，et al. Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients [J]. Int J Endocrinol，2017，2017：2645904.
[6] Liu N，Zhou Q，Qi YH，et al. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis [J]. Exp Mol Pathol，2017，103（1）：71-77.
[7] Zhou Y，Zhang X，Klibanski A. MEG3 noncoding RNA：a tumor suppressor [J]. J Mol Endocrinol，2012，48（3）：R45-R53.
[8] Kentwell J，Gundara JS，Sidhu SB. Noncoding RNAs in endocrine malignancy [J]. Oncologist，2014，19（5）：483-491.
[9] Bunch H. Gene regulation of mammalian long non-coding RNA [J]. Mol Genet Genomics，2017.doi：10.1007/s00438-017-1370-9.
[10] Zhao JJ，Hao S，Wang LL，et al. Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-beta/Smad signaling pathway [J]. Oncotarget，2016，7（36）：57 903-57 918.
[11] Xu B，Shao Q，Xie K，et al. The Long Non-Coding RNA ENST00000537266 and ENST00000426615 Influence Papillary Thyroid Cancer Cell Proliferation and Motility [J]. Cell Physiol Biochem，2016，38（1）：368-378.
[12] Li Q，Shen W，Li X，et al. The lncRNA n340790 accelerates carcinogenesis of thyroid cancer by regulating miR-1254 [J]. Am J Transl Res，2017，9（5）：2181-2194.
[13] Li Z，Gao B，Hao S，et al. Knockdown of lncRNA-PANDAR suppresses the proliferation，cell cycle and promotes apoptosis in thyroid cancer cells [J]. EXCLI J，2017，16：354-362.
[14] Dong Z，Zhang A，Liu S，et al. Aberrant Methylation-mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer [J]. Mol Cancer Res，2017，15（7）：800-810.
[15] Zhang W，Shi S，Jiang J，et al. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer [J]. Biomed Pharmacother，2017，91：312-319.
[16] Li J，Bian EB，He XJ，et al. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas [J]. Int J Oncol，2016，48（2）：723-733.
[17] Sheng X，Li J，Yang L，et al. Promoter hypermethylation influences the suppressive role of maternally expressed 3，a long non-coding RNA，in the development of epithelial ovarian cancer [J]. Oncol Rep，2014，32（1）：277-285.
[18] Yan J，Guo X，Xia J，et al. MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1 [J]. Med Oncol，2014，31（3）：879.
[19] Ying L，Huang Y，Chen H，et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer [J]. Mol Biosyst，2013，9（3）：407-411.
[20] Zhang J，Yao T，Wang Y，et al. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21 [J]. Cancer Biol Ther，2016，17（1）：104-113.